Transthyretin Amyloidosis Cardiomyopathy, Heart Failure With Preserved Ejection Fraction
1 clinical trials · Condition
◉ Watch Transthyretin Amyloidosis Cardiomyopathy, Heart Failure With Preserved Ejection Fraction
| Record | Firm | Date |
|---|---|---|
| Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in Russia (NCT06338839) | AstraZeneca | 2023-12-28 |
Track Transthyretin Amyloidosis Cardiomyopathy, Heart Failure With Preserved Ejection Fraction automatically
Every clearance here is in the API, with alerts when new ones post.